These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11258664)

  • 61. Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells.
    Habrukowich C; Han DK; Le A; Rezaul K; Pan W; Ghosh M; Li Z; Dodge-Kafka K; Jiang X; Bittman R; Hla T
    J Biol Chem; 2010 Aug; 285(35):26825-26831. PubMed ID: 20558741
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function.
    Wattenberg BW; Pitson SM; Raben DM
    J Lipid Res; 2006 Jun; 47(6):1128-39. PubMed ID: 16520486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sphingosine kinase-1: a potential mediator of renal fibrosis.
    Long DA; Price KL
    Kidney Int; 2009 Oct; 76(8):815-7. PubMed ID: 19789541
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endothelin-1 stimulates sphingosine kinase in human hepatic stellate cells. A novel role for sphingosine-1-P as a mediator of growth inhibition.
    Gallois C; Davaille J; Habib A; Mallat A; Tao J; Levade T; Lotersztajn S
    Ann N Y Acad Sci; 2000 Apr; 905():311-4. PubMed ID: 10818472
    [No Abstract]   [Full Text] [Related]  

  • 65. Phosphorylated cis-4-methylsphingosine mimics the mitogenic effect of sphingosine-1-phosphate in Swiss 3T3 fibroblasts.
    van Echten-Deckert G; Schick A; Heinemann T; Schnieders B
    J Biol Chem; 1998 Sep; 273(36):23585-9. PubMed ID: 9722598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Two forms of membrane-bound sphingosine kinase in Tetrahymena and activity changes during growth and the cell cycle.
    Wang S; Banno Y; Nozawa Y
    J Eukaryot Microbiol; 2002; 49(4):305-11. PubMed ID: 12188220
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Advances in thrombin-protease-activated receptor 1-sphingosine 1-phosphate pathway during sepsis].
    Li Y; Yu KL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):189-91. PubMed ID: 19278594
    [No Abstract]   [Full Text] [Related]  

  • 68. Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function.
    Blaukat A; Pizard A; Breit A; Wernstedt C; Alhenc-Gelas F; Muller-Esterl W; Dikic I
    J Biol Chem; 2001 Nov; 276(44):40431-40. PubMed ID: 11517230
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sphingosine 1-phosphate, a key cell signaling molecule.
    Spiegel S; Milstien S
    J Biol Chem; 2002 Jul; 277(29):25851-4. PubMed ID: 12011102
    [No Abstract]   [Full Text] [Related]  

  • 70. Sphingosine kinase inhibitors in the apoptosis of leukaemia cells.
    Pallis M
    Leuk Res; 2002 Apr; 26(4):415-6. PubMed ID: 11839389
    [No Abstract]   [Full Text] [Related]  

  • 71. Structure and signalling pathways of kinin receptors.
    Blaukat A
    Andrologia; 2003 Feb; 35(1):17-23. PubMed ID: 12558525
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitors of the sphingosine kinase pathway as potential therapeutics.
    Pitman MR; Pitson SM
    Curr Cancer Drug Targets; 2010 Jun; 10(4):354-67. PubMed ID: 20370685
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis and biological evaluation of carbocyclic analogues of pachastrissamine.
    Kwon Y; Song J; Bae H; Kim WJ; Lee JY; Han GH; Lee SK; Kim S
    Mar Drugs; 2015 Feb; 13(2):824-37. PubMed ID: 25654428
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sphingosine kinase A is a pleiotropic and essential enzyme for Leishmania survival and virulence.
    Zhang O; Hsu FF; Xu W; Pawlowic M; Zhang K
    Mol Microbiol; 2013 Nov; 90(3):489-501. PubMed ID: 23980754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival.
    Lim KG; Gray AI; Pyne S; Pyne NJ
    Br J Pharmacol; 2012 Jul; 166(5):1605-16. PubMed ID: 22251058
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sphingosine kinase-signaling pathway: a possible therapeutic target for post-operative cognitive dysfunction.
    Yang J; Ji M; Zhou Z; Sun J; Peng Y
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):260-1. PubMed ID: 22091624
    [No Abstract]   [Full Text] [Related]  

  • 77. Bradykinin B2 receptors and signal transduction analyzed in NG108-15 neuroblastoma x glioma hybrid cells, B2 receptor-transformed CHO cells and ras-transformed NIH/3T3 fibroblasts.
    Higashida H; Hashii M; Yokoyama S; Taketo M; Hoshi N; Noda M; Zhong ZG; Shahidullah M; Minabe Y; Nakashima S; Nozawa Y
    Prog Brain Res; 1996; 113():215-30. PubMed ID: 9009737
    [No Abstract]   [Full Text] [Related]  

  • 78. S-15183a and b, new sphingosine kinase inhibitors, produced by a fungus.
    Kono K; Tanaka M; Ono Y; Hosoya T; Ogita T; Kohama T
    J Antibiot (Tokyo); 2001 May; 54(5):415-20. PubMed ID: 11480884
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways.
    Buehrer BM; Bell RM
    J Biol Chem; 1992 Feb; 267(5):3154-9. PubMed ID: 1310683
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Not a small frog in a big pond: targeting bradykinin receptor B2 signaling in vascular smooth muscle cells for treatment of hypertension.
    Higashikuni Y; Liu W; Sata M
    Hypertens Res; 2023 Oct; 46(10):2415-2418. PubMed ID: 37507534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.